Naltrexone for reducing self-harm behaviors
Treatments studied
Part of Mental health clinical trials.
This study tests whether the medication naltrexone can help reduce self-harm urges or actions in people who hurt themselves without intending suicide. It may offer a new option if current treatments haven't been enough.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 16 years old.
- You must have self-harmed without suicidal intent in a way that causes significant distress or impairment.
- You must be able to attend clinic visits and take the study medication as directed.
- You must not be using opioids (like heroin or prescription painkillers) or certain other medications that could interact with naltrexone.
- If you are a woman able to have children, you must have a negative pregnancy test and use effective birth control during the study.
- You must not have serious suicidal thoughts or be at high risk of suicide right now.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called naltrexone can help reduce the urge or behavior of self-injury (hurting yourself on purpose) in people who have not improved with standard treatment. It may offer a new option to manage these urges.
This Phase 4 study tests whether naltrexone injections can help people with alcohol use disorder (AUD) reduce or stop heavy drinking. You may get two injections over 8 weeks, and you can join if you meet specific drinking pattern and eligibility rules.
This study tests a long-acting implant that releases naltrexone slowly over time to help prevent relapse in people with opioid use disorder. The implant is placed under the skin in a minor procedure and may help you stay opioid-free.
This Phase 2 study tests whether low-dose naltrexone can reduce pain from vulvodynia. It also looks at how well it works across different vulvodynia types, comparing to what participants are already doing for symptoms.
This trial tests whether naltrexone, a medication that blocks the effects of opioids, can help prevent overdose in people who use stimulants like cocaine or methamphetamine. It may be a good fit if you are at risk for HIV or living with HIV, and have a stimulant use disorder or use stimulants at least 10 days per month.
This study tests a new implant (BICX104) with or without bupropion to see how safe it is and how it works in the body, compared to an existing treatment (Vivitrol). If you are healthy and not using opioids, you may be eligible to help researchers understand if this implant could be a new option for treatment.
Hear when a new Nonsuicidal Self Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.